Mehmet Tevfik Dorak

Title: Innovations by Mehmet Tevfik Dorak

Introduction

Mehmet Tevfik Dorak is an accomplished inventor based in Pembroke, FL (US). He has made significant contributions to the field of medical diagnostics, particularly in the area of childhood leukemia and prenatal loss. With a total of 2 patents, his work has the potential to impact healthcare positively.

Latest Patents

Dorak's latest patents include groundbreaking inventions that focus on genetic markers. The first patent, titled "Haplotype tagging single nucleotide polymorphisms and use of same to predict childhood lymphoblastic leukemia," introduces novel haplotype tagging SNPs that serve as reliable biomarkers for a decreased risk of childhood lymphoblastic leukemia (ALL). This invention provides methods and reagents for assessing specific SNPs, including rs807212, rs198853, rs9467664, rs2213284, rs2230655, and rs12346. The second patent, "Single nucleotide polymorphisms and use of same predicting male-specific prenatal loss," presents a panel of SNPs that act as biomarkers for sex-specific prenatal loss of a conceptus or embryo. This invention also includes methods and reagents for assessing these specific SNPs.

Career Highlights

Dorak is currently associated with Medical Diagnostic Laboratories, LLC, where he continues to innovate in the field of medical diagnostics. His work is characterized by a commitment to improving predictive methods for serious health conditions.

Collaborations

Some of his notable coworkers include Charronne Florence Davis and Esma Ucisik-Akkaya, who contribute to the collaborative environment at Medical Diagnostic Laboratories.

Conclusion

Mehmet Tevfik Dorak's contributions to medical diagnostics through his innovative patents highlight his role as a significant inventor in the field. His work not only advances scientific understanding but also has the potential to improve patient outcomes in critical areas of healthcare.